{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Foreign", "lead_paragraph": "A drug that was sold for decades despite red flags has prompted questions about the cozy relationship between drug makers, doctors and regulators.", "headline": {"seo": "Scandal Widens Over French Weight-Loss Drug Mediator", "main": "Scandal Over Mediator, a French Weight-Loss Drug, Prompts Calls for Wide Changes", "print_headline": "Scandal Over Mediator, a French Weight-Loss Drug, Prompts Calls for Wide Changes"}, "abstract": "Growing public health scandal over French diabetes drug Mediator, which was sold for decades despite concerns over its safety, is raising serious questions about the cozy relationships among drug makers, doctors and regulators in France.", "print_page": "7", "word_count": "1218", "_id": "515b81befdc59278db00b986", "snippet": "A drug that was sold for decades despite red flags has prompted questions about the cozy relationship between drug makers, doctors and regulators.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2011/12/12/health/scandal-widens-over-french-weight-loss-drug-mediator.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "France", "is_major": "Y", "rank": "1", "name": "glocations"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Weight", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Diabetes", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "7", "name": "subject"}, {"value": "Regulation and Deregulation of Industry", "is_major": "N", "rank": "8", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Scott", "lastname": "SAYARE"}], "original": "By SCOTT SAYARE"}, "document_type": "article", "pub_date": "2011-12-12T00:00:00Z", "section_name": "Health"}, {"type_of_material": "Blog", "blog": [], "news_desk": null, "lead_paragraph": null, "headline": {"main": "Should the Morning-After Pill Be Sold Over the Counter to People Under 17?", "kicker": "The Learning Network Blog"}, "abstract": "Student Opinion | Read the related articles and tell us what you think about recent decision by the United States secretary of health.", "print_page": null, "word_count": "473", "_id": "54f351d379881075cd2202aa", "snippet": "Student Opinion | Read the related articles and tell us what you think about recent decision by the United States secretary of health.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://learning.blogs.nytimes.com/2011/12/09/should-the-morning-after-pill-be-sold-over-the-counter-to-people-under-17/", "multimedia": [], "subsection_name": "Education", "keywords": [], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Katherine", "lastname": "SCHULTEN"}], "original": "By KATHERINE SCHULTEN"}, "document_type": "blogpost", "pub_date": "2011-12-09T05:22:25Z", "section_name": "U.S."}, {"type_of_material": "Blog", "blog": [], "news_desk": null, "lead_paragraph": "The United States secretary of health publicly overruled the Food and Drug Administration this week, refusing to allow emergency contraception known as the \"morning-after pill\" to be sold without a prescription to people under 17. (If taken soon after unprotected sex, the pill halves the chances of a pregnancy.)", "headline": {"main": "Should the Morning-After Pill Be Sold Over the Counter to People Under 17?", "kicker": "The Learning Network"}, "abstract": "Student Opinion | Read the related articles and tell us what you think about recent decision by the United States secretary of health.", "print_page": null, "word_count": 463, "_id": "4fd3a2618eb7c8105d8ea451", "snippet": "Student Opinion | Read the related articles and tell us what you think about recent decision by the United States secretary of health.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://learning.blogs.nytimes.com/2011/12/09/should-the-morning-after-pill-be-sold-over-the-counter-to-people-under-17/", "multimedia": [], "subsection_name": null, "keywords": [{"value": "News", "name": "type_of_material", "rank": "1"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Katherine", "lastname": "SCHULTEN"}], "original": "By KATHERINE SCHULTEN"}, "document_type": "blogpost", "pub_date": "2011-12-09T05:22:25Z", "section_name": "U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "National", "lead_paragraph": "President Obama, citing his role as a father, backed his health secretary\u2019s decision to block over-the-counter sales of an after-sex contraceptive pill to girls under age 17.", "headline": {"main": "Obama Endorses Decision to Limit Morning-After Pill", "print_headline": "Obama Backs Aide\u2019s Stance on Morning-After Pill"}, "abstract": "Pres Obama endorses Secretary of Health and Human Services Kathleen Sebelius's decision to block over-the-counter sales of emergency contraception to girls under age 17; disappointed supporters in the scientific and women's rights communities question whether the decision is political, as Obama sidesteps a skirmish with conservatives in the nation's culture wars by endorsing the decision.", "print_page": "20", "word_count": "1119", "_id": "515b8254fdc59278db00ba3d", "snippet": "President Obama, citing his role as a father, backed his health secretary\u2019s decision to block over-the-counter sales of an after-sex contraceptive pill to girls under age 17.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2011/12/09/us/obama-backs-aides-stance-on-morning-after-pill.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Plan B (Contraceptive)", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Obama, Barack", "is_major": "N", "rank": "2", "name": "persons"}, {"value": "Presidential Election of 2012", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Birth Control and Family Planning", "is_major": "Y", "rank": "4", "name": "subject"}, {"value": "Sebelius, Kathleen", "is_major": "Y", "rank": "5", "name": "persons"}, {"value": "Women and Girls", "is_major": "N", "rank": "6", "name": "subject"}, {"value": "United States Politics and Government", "is_major": "N", "rank": "7", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "8", "name": "subject"}, {"value": "Food and Drug Administration", "is_major": "N", "rank": "9", "name": "organizations"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Jackie", "lastname": "CALMES"}, {"organization": "", "role": "reported", "rank": 2, "firstname": "Gardiner", "lastname": "HARRIS"}], "original": "By JACKIE CALMES and GARDINER HARRIS"}, "document_type": "article", "pub_date": "2011-12-09T00:00:00Z", "section_name": "U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Foreign", "lead_paragraph": "The used batteries Americans turn in for recycling are increasingly processed in Mexico, their lead often extracted by crude methods that are illegal in the United States.", "headline": {"seo": "Recycled Battery Lead Puts Mexicans in Danger", "main": "Lead From Old U.S. Batteries Sent to Mexico Raises Risks", "print_headline": "Used Batteries From U.S. Expose Mexicans to Risk"}, "abstract": "Used batteries Americans turn in for recycling are increasingly processed in Mexico, their lead often extracted by crude methods that are illegal in the United States, exposing workers and residents there to dangerous levels of a toxic metal; rising flow of batteries is result of strict Environmental Protection Agency standards on lead pollution, which make domestic recycling more difficult but do not prohibit companies from exporting the work to countries where standards are low.", "print_page": "1", "word_count": "2830", "_id": "515b827bfdc59278db00ba6d", "snippet": "The used batteries Americans turn in for recycling are increasingly processed in Mexico, their lead often extracted by crude methods that are illegal in the United States.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2011/12/09/science/earth/recycled-battery-lead-puts-mexicans-in-danger.html", "multimedia": [{"subtype": "xlarge", "url": "images/2011/12/09/world/jpbattery1/jpbattery1-articleLarge.jpg", "height": 330, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2011/12/09/world/jpbattery1/jpbattery1-articleLarge.jpg", "xlargeheight": "330"}, "type": "image"}], "subsection_name": "Environment", "keywords": [{"value": "Hazardous and Toxic Substances", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Batteries", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Automobiles", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Mexico", "is_major": "Y", "rank": "4", "name": "glocations"}, {"value": "Recycling of Waste Materials", "is_major": "Y", "rank": "5", "name": "subject"}, {"value": "Lead", "is_major": "Y", "rank": "6", "name": "subject"}], "byline": {"contributor": "Andrew W. Lehren contributed reporting from New York, and Karla Zabludovsky from Mexico City. David Agren contributed research from Guadalajara, Mexico.", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Elisabeth", "lastname": "ROSENTHAL"}], "original": "By ELISABETH ROSENTHAL"}, "document_type": "article", "pub_date": "2011-12-09T00:00:00Z", "section_name": "Science"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "Clinical trials of the treatments, from Novartis and Genentech, showed they could lengthen lives.", "headline": {"seo": "Two Drugs Appear to Delay Progression of Breast Cancer", "main": "Two Drugs Appear to Delay Progression of Breast Cancer", "print_headline": "Two Drugs Appear to Delay Progression of Breast Cancer"}, "abstract": "Researchers report two drugs, pertuzumab from Genentech and everolimus from Novartis, can delay by several months the time before advanced breast cancer worsens, potentially providing new options for women with the disease.", "print_page": "3", "word_count": "813", "_id": "515b82bffdc59278db00babb", "snippet": "Clinical trials of the treatments, from Novartis and Genentech, showed they could lengthen lives.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2011/12/08/health/research/two-drugs-appear-to-delay-progression-of-breast-cancer.html", "multimedia": [], "subsection_name": "Research", "keywords": [{"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Breast Cancer", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Novartis A.G", "is_major": "Y", "rank": "3", "name": "organizations"}, {"value": "Genentech Inc", "is_major": "Y", "rank": "4", "name": "organizations"}, {"value": "Research", "is_major": "N", "rank": "5", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2011-12-08T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "National", "lead_paragraph": "The health secretary overruled the Food and Drug Administration\u2019s decision that emergency contraceptives be sold freely over the counter, including to teenagers 16 years old and younger.", "headline": {"seo": "Sebelius Overrules F.D.A. on Freer Sale of Emergency Contraceptives", "main": "Plan to Widen Availability of Morning-After Pill Is Rejected", "print_headline": "F.D.A. Overruled On Availability Of After-Sex Pill"}, "abstract": "Health and Human Services Secretary Kathleen Sebelius overrules the Food and Drug Administration, refusing to allow emergency contraceptives to be sold over the counter, including to young teenagers; it is the first time that the HHS has overruled the FDA and the decision avoids what could have been a bruising political battle over parental control and contraception.", "print_page": "1", "word_count": "1253", "_id": "515b82e3fdc59278db00bae8", "snippet": "The health secretary overruled the Food and Drug Administration\u2019s decision that emergency contraceptives be sold freely over the counter, including to teenagers 16 years old and younger.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2011/12/08/health/policy/sebelius-overrules-fda-on-freer-sale-of-emergency-contraceptives.html", "multimedia": [{"subtype": "thumbnail", "url": "images/2011/12/08/us/FDA1/FDA1-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2011/12/08/us/FDA1/FDA1-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": "Money & Policy", "keywords": [{"value": "Sebelius, Kathleen", "is_major": "Y", "rank": "1", "name": "persons"}, {"value": "Food and Drug Administration", "is_major": "Y", "rank": "2", "name": "organizations"}, {"value": "Plan B (Contraceptive)", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Birth Control and Family Planning", "is_major": "Y", "rank": "4", "name": "subject"}, {"value": "Presidential Election of 2012", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Health and Human Services Department", "is_major": "N", "rank": "6", "name": "organizations"}, {"value": "Teenagers and Adolescence", "is_major": "N", "rank": "7", "name": "subject"}, {"value": "Hamburg, Margaret A", "is_major": "N", "rank": "8", "name": "persons"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Gardiner", "lastname": "HARRIS"}], "original": "By GARDINER HARRIS"}, "document_type": "article", "pub_date": "2011-12-08T00:00:00Z", "section_name": "Health"}], "meta": {"hits": 7, "offset": 0, "time": 37}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}